Tryp Therapeutics Inc (TRYPF) Corporate Presentation

Corporate Presentation Fall 2021 UNLEASHING THE FULL POTENTIAL OF PSILOCYBIN Tryp differs from other psychedelic drug development companies in four important ways: 8 The right people at the right time We have assembled foremost experts in drug development and psychedelics within Tryp while partnering with academic collaborators with unrivaled leadership within their respective indications. Our Scientific Advisor Board is chaired by Robin Carhart-Harris, PhD, a preeminent, global expert on the clinical application of psychedelics. 04